This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Université Pierre Et Marie Curie (Paris Vi), Universitè De Genève. Active years: 2007-2011.
Company Filing History:
2 out of 42 
1 out of 71 
Years Active: 2007-2011
Title: Karim Dorgham: Innovator in Chemokine Variants
Introduction
Karim Dorgham is a notable inventor based in Ivry sur Seine, France. He has made significant contributions to the field of chemokine variants, holding 2 patents that focus on innovative methods for construction and screening.
Latest Patents
His latest patents include methods for the design and selection of agonist or antagonist chemokine variants. These inventions utilize phage display technology and involve screening on living cells that express the receptor of the corresponding native chemokine. Additionally, his patents provide RANTES variants that exhibit agonist properties towards said receptor. They also outline methods for preventing and curing viral diseases, as well as insights for addressing inflammatory or malignant diseases.
Career Highlights
Karim has worked with prestigious institutions such as Université Pierre et Marie Curie (Paris VI) and Université de Genève. His work has contributed to advancements in the understanding and application of chemokine variants in medical research.
Collaborations
Some of his notable coworkers include Guy Gorochov and Oliver Hartley, who have collaborated with him on various projects related to his patents.
Conclusion
Karim Dorgham's innovative work in chemokine variants showcases his dedication to advancing medical science. His contributions are significant in the ongoing efforts to develop treatments for various diseases.